West Pharmaceutical Services Comprehensive Income 2010-2024 | WST

West Pharmaceutical Services comprehensive income for the quarter ending December 31, 2024 was $-0.258B, a 79.49% increase year-over-year.

  • West Pharmaceutical Services comprehensive income for 2024 was $-0.258B, a 79.49% increase from 2023.
  • West Pharmaceutical Services comprehensive income for 2023 was $-0.144B, a 21.42% decline from 2022.
  • West Pharmaceutical Services comprehensive income for 2022 was $-0.183B, a 14.66% increase from 2021.

West Pharmaceutical Services Comprehensive Income 2010-2024 | WST

  • West Pharmaceutical Services comprehensive income for 2024 was $-0.258B, a 79.49% increase from 2023.
  • West Pharmaceutical Services comprehensive income for 2023 was $-0.144B, a 21.42% decline from 2022.
  • West Pharmaceutical Services comprehensive income for 2022 was $-0.183B, a 14.66% increase from 2021.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$75.5B
Becton Dickinson (BDX)$65.3B
Cardinal Health (CAH)$30.6B
Straumann Holding AG (SAUHY)$23.7B
Labcorp (LH)$20.7B
Cooper (COO)$17.3B
Align Technology (ALGN)$15.1B
Henry Schein (HSIC)$9.7B
Merit Medical Systems (MMSI)$6.2B
DENTSPLY SIRONA (XRAY)$3.8B
Patterson (PDCO)$2.7B
CONMED (CNMD)$1.9B
STAAR Surgical (STAA)$876M
Lifevantage (LFVN)$230M
Pro-Dex (PDEX)$112M